Tech Company Financing Transactions

Sorbent Therapeutics Funding Round

Sorbent Therapeutics secured a $36 million Series B venture capital round on 6/30/2011. Investors included Novartis Venture Fund, AgeChem Venture Fund and Arch Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

710 Lakeway Dr. 290
Sunnyvale, CA 94085
USA

Phone

(408) 738-8240

Website

www.sorbentrx.com

Email Address

[email protected]

Overview

Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Detlef Albrecht

        

Chief Financial Officer

Tom O'Neil

        

Chief Medical Officer

Howard Dittrich

        

VP - Bus. Development

Linda De Young

        

Browse more venture capital transactions:

Prev: 6/30/2011: Valen Technologies venture capital transaction
Next: 6/30/2011: Neoconix venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary